Pre-Operative Intra-Aortic Balloon Pump (Iabp) Decreases Mortality and Major Adverse Cardiovascular and Cerebrovascular Events (Macce) in High-Risk Coronary Artery Bypass (Cabg) Patients

Rampersad, Penelope; Zawi, Rami; Overgaard, C.B.; Ouzounian, Maral; Sharma, Vishal; Rao, V.; Farkouh, Michael E.; Udell, Jacob A.; Džavík, Vladimir

doi:10.1016/j.cjca.2015.07.383

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Studies showed only some benefit from preoperative use of levosimendan in patients undergoing isolated CABG [16][17][18]. While a meta-analysis of randomized trials came to the conclusion that prophylactic IABP use may reduce short-term mortality and major adverse cardiac and cerebrovascular events in high-risk patients with a mean LV-EF of 35% undergoing elective or urgent CABG [19], another study was unable to determine survival advantages of using prophylactic IABP in high-risk patients undergoing CABG [20]. ECLS is the current standard approach to treat PCS after cardiac surgery.…”

Section: Discussionmentioning

confidence: 99%

Preventive Impella® Support in High-Risk Patients Undergoing Cardiac Surgery

Benke

Korça

Boltjes

et al. 2022

JCM

View full text Add to dashboard Cite

Background: Patients with severely reduced LV-EF ≤ 30% undergoing CABG have a high risk for postoperative cardiogenic shock. The optimal timing of an adequate hemodynamic support has an impact on short- and midterm mortality after CABG. This study aimed to assess the prophylactic use of the Impella pump in high-risk patients undergoing elective cardiac surgery. Methods: In this single-center retrospective study, 14 patients with LV-EF (≤30%) undergoing cardiac surgery received a prophylactic, perioperative Impella (5.0, 5.5) support between 2020 and 2022. Results: The mean age at surgery was 64.2 ± 2.6 years, the mean preoperative LV-EF was 20.7% ± 1.56%. The duration of Impella support was 4 (3–7.8) days and the 30-day survival rate was 92.85%. Acute renal failure occurred in four patients who were dialyzed on average for 1.2 ± 0.7 days. Mechanical ventilation was needed for 1.75 (0.9–2.7) days. Time to inotrope/vasopressor independence was 2 (0.97–7.25) days with a highest lactate level (24 h postoperatively) of 3.8 ± 0.6 mmol/l. Postoperative LV-EF showed a significant improvement when compared to preoperative LV-EF (29.1% ± 2.6% vs. 20.7% ± 1.56% (p = 0.022)). Conclusion: The prophylactic Impella application seems to be a safe approach to improve the outcomes of this patient population.

show abstract

Section: Discussionmentioning

confidence: 99%

Preventive Impella® Support in High-Risk Patients Undergoing Cardiac Surgery

Benke

Korça

Boltjes

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

“…Eldri rannsóknir erlendis hafa þó sýnt að ósaeðardaela geti haft jákvaeð áhrif hvað varðar MACCE-fría lifun. [28][29][30] Almennt var tíðni alvarlegra fylgikvilla ekki há og flestir fylgikvillar sem tengdust daelunni voru minniháttar. Þannig fengu 14,1% sjúklinga einhvern fylgikvilla tengdan ósaeðardaelunni og er það svipað hlutfall og í rannsókn Valente og félaga.…”

Section: R a N N S ó K Nunclassified

Notkun ósæðardælu við kransæðahjáveituaðgerðir

Gunnarsdottir

Heimisdottir

et al. 2020

LBL

View full text Add to dashboard Cite

Pre-Operative Intra-Aortic Balloon Pump (Iabp) Decreases Mortality and Major Adverse Cardiovascular and Cerebrovascular Events (Macce) in High-Risk Coronary Artery Bypass (Cabg) Patients

Cited by 2 publications

References 0 publications

Preventive Impella® Support in High-Risk Patients Undergoing Cardiac Surgery

Preventive Impella® Support in High-Risk Patients Undergoing Cardiac Surgery

Notkun ósæðardælu við kransæðahjáveituaðgerðir

Contact Info

Product

Resources

About